William H. Bisson

67 papers receiving 5.6k citations

William H. Bisson's Hit Papers

Gut microbiota and intestinal FXR mediate the clinical benefits of metformin 2018 · 850 citations
8500+3+7Years since publication250500750

Peers

William H. Bisson
Comparison fields: 5 of 134
  • Health, Toxicology and Mutagenesis 1k
  • Biological Psychiatry 73
  • Molecular Biology 2.3k
  • Cancer Research 437
  • Pharmacology 283
Replace Jack U. Flanagan with:
Jack U. Flanagan New Zealand
Jan Vondráček Czechia
Colin J. Henderson United Kingdom
James L. Stevens United States
Curtis J. Omiecinski United States
Shantu Amin United States
Po‐Lin Kuo Taiwan
David M. Siegel United States
Dalei Wu China
Dominique Lagadic‐Gossmann France
William H. Bisson relative to Jack U. Flanagan New Zealand Jack U. Flanagan's profile →
Citations per field
00.5×2×2.9×
Jack U. Flanagan · 1×
Citations per year

Countries citing papers authored by William H. Bisson

Since Specialization
Citations

This map shows the geographic impact of William H. Bisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William H. Bisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William H. Bisson more than expected).

Fields of papers citing papers by William H. Bisson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William H. Bisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William H. Bisson. The network helps show where William H. Bisson may publish in the future.

Co-authors

The 25 scholars most cited alongside William H. Bisson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William H. Bisson Line = papers co-authored together William H. Bisson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
Hit paper breakdown →
2018850
2
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
Hit paper breakdown →
2015501
3 2015327
4 2015270
5 2010224
6 2017215
7 2015191
8 2018188
9 2015178
10 2009126
11 2017125
12 2010112
13 2015109
14 2013107
15 201596
16 201195
17 201495
18 200786
19 201281
20 200978

About William H. Bisson

William H. Bisson is a scholar working on Health, Toxicology and Mutagenesis, Molecular Biology, Cancer Research, Oncology and Pharmacology, having authored 68 papers that have together received 5.8k indexed citations. Recurring topics across this work include Toxic Organic Pollutants Impact (14 papers), Carcinogens and Genotoxicity Assessment (8 papers), Histone Deacetylase Inhibitors Research (5 papers), Lung Cancer Treatments and Mutations (5 papers), Computational Drug Discovery Methods (5 papers), Immunotoxicology and immune responses (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (1k citations), Biological Psychiatry (73 citations), Molecular Biology (2.3k citations), Cancer Research (437 citations) and Pharmacology (283 citations). William H. Bisson has collaborated with scholars based in United States, Italy and Switzerland. Frequent co-authors include Siva K. Kolluri, Roderick H. Dashwood, Daniel C. Koch, Andrew D. Patterson, Shantu Amin, Robert L. Tanguay, Gary H. Perdew, Nancy Isaacson Kerkvliet, Iain A. Murray and Edmond F. O’Donnell. Their work appears in journals such as Carcinogenesis, Toxicological Sciences, Journal of Medicinal Chemistry, Cell Death and Disease and European Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact